These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11851041)

  • 1. [Microbial resistance to antibiotics from the clinical viewpoint. Paradoxical therapy failures and the significance of pharmacokinetic-pharmacodynamic interactions in vivo].
    Rossi M; Gerber AU
    Ther Umsch; 2002 Jan; 59(1):11-9. PubMed ID: 11851041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
    Bland CM; Pai MP; Lodise TP
    Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.
    Burgess DS
    Chest; 1999 Mar; 115(3 Suppl):19S-23S. PubMed ID: 10084455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the dose matter?
    Craig WA
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S233-7. PubMed ID: 11524724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
    Andes D; Anon J; Jacobs MR; Craig WA
    Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
    Reed MD
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic factors of antibiotic efficacy.
    Rotschafer JC; Zabinski RA; Walker KJ
    Pharmacotherapy; 1992; 12(6 Pt 2):64S-70S. PubMed ID: 1480502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological indices in antibiotic therapy.
    Barger A; Fuhst C; Wiedemann B
    J Antimicrob Chemother; 2003 Dec; 52(6):893-8. PubMed ID: 14613960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic antimicrobial agents for postoperative infections: appropriate use of antibiotics from the viewpoint of pharmacokinetic/pharmacodynamic theory].
    Takesue Y; Nakajima K; Wada Y; Ichiki K; Yanagi H; Ikeuchi H
    Nihon Geka Gakkai Zasshi; 2006 Sep; 107(5):224-9. PubMed ID: 17017418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.